Familial AD (fAD)-causing mutations in genes such as PSEN1 and APP are well studied in this context and are known to drive mutation-specific changes in the stoichiometry of Aβ processing, both in cell-based in vitro models and in vivo.7–9. This evidence concerns the gene PSEN1 and familial Alzheimer disease.